These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 9401937)
1. Effects of different absorption enhancers on the permeation of ebiratide, an ACTH analogue, across intestinal membranes. Yamamoto A; Okagawa T; Kotani A; Uchiyama T; Shimura T; Tabata S; Kondo S; Muranishi S J Pharm Pharmacol; 1997 Nov; 49(11):1057-61. PubMed ID: 9401937 [TBL] [Abstract][Full Text] [Related]
2. Enhanced permeability of insulin across the rat intestinal membrane by various absorption enhancers: their intestinal mucosal toxicity and absorption-enhancing mechanism of n-lauryl-beta-D-maltopyranoside. Uchiyama T; Sugiyama T; Quan YS; Kotani A; Okada N; Fujita T; Muranishi S; Yamamoto A J Pharm Pharmacol; 1999 Nov; 51(11):1241-50. PubMed ID: 10632081 [TBL] [Abstract][Full Text] [Related]
3. Susceptibility of ebiratide to proteolysis in rat intestinal fluid and homogenates and its protection by various protease inhibitors. Okagawa T; Fujita T; Murakami M; Yamamoto A; Shimura T; Tabata S; Kondo S; Muranishi S Life Sci; 1994; 55(9):677-83. PubMed ID: 8065230 [TBL] [Abstract][Full Text] [Related]
4. Excellent absorption enhancing characteristics of NO donors for improving the intestinal absorption of poorly absorbable compound compared with conventional absorption enhancers. Fetih G; Habib F; Katsumi H; Okada N; Fujita T; Attia M; Yamamoto A Drug Metab Pharmacokinet; 2006 Jun; 21(3):222-9. PubMed ID: 16858126 [TBL] [Abstract][Full Text] [Related]
5. In-vivo blood-brain barrier transport of a novel adrenocorticotropic hormone analogue, ebiratide, demonstrated by brain microdialysis and capillary depletion methods. Shimura T; Tabata S; Terasaki T; Deguchi Y; Tsuji A J Pharm Pharmacol; 1992 Jul; 44(7):583-8. PubMed ID: 1357139 [TBL] [Abstract][Full Text] [Related]
6. Transport mechanism of a new behaviorally highly potent adrenocorticotropic hormone (ACTH) analog, ebiratide, through the blood-brain barrier. Shimura T; Tabata S; Ohnishi T; Terasaki T; Tsuji A J Pharmacol Exp Ther; 1991 Aug; 258(2):459-65. PubMed ID: 1650827 [TBL] [Abstract][Full Text] [Related]
7. Site-dependent effect of aprotinin, sodium caprate, Na2EDTA and sodium glycocholate on intestinal absorption of insulin. Morishita M; Morishita I; Takayama K; Machida Y; Nagai T Biol Pharm Bull; 1993 Jan; 16(1):68-72. PubMed ID: 7690292 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects of the intestinal permeation enhancers, SNAC and sodium caprate (C Twarog C; McCartney F; Harrison SM; Illel B; Fattal E; Brayden DJ Eur J Pharm Sci; 2021 Mar; 158():105685. PubMed ID: 33359131 [TBL] [Abstract][Full Text] [Related]
10. Absorptive-mediated endocytosis of an adrenocorticotropic hormone (ACTH) analogue, ebiratide, into the blood-brain barrier: studies with monolayers of primary cultured bovine brain capillary endothelial cells. Terasaki T; Takakuwa S; Saheki A; Moritani S; Shimura T; Tabata S; Tsuji A Pharm Res; 1992 Apr; 9(4):529-34. PubMed ID: 1323100 [TBL] [Abstract][Full Text] [Related]
11. Sodium caprate enables the blood pressure-lowering effect of Ile-Pro-Pro and Leu-Lys-Pro in spontaneously hypertensive rats by indirectly overcoming PepT1 inhibition. Gleeson JP; Frías JM; Ryan SM; Brayden DJ Eur J Pharm Biopharm; 2018 Jul; 128():179-187. PubMed ID: 29684535 [TBL] [Abstract][Full Text] [Related]
12. Salcaprozate sodium (SNAC) enhances permeability of octreotide across isolated rat and human intestinal epithelial mucosae in Ussing chambers. Fattah S; Ismaiel M; Murphy B; Rulikowska A; Frias JM; Winter DC; Brayden DJ Eur J Pharm Sci; 2020 Nov; 154():105509. PubMed ID: 32777258 [TBL] [Abstract][Full Text] [Related]
13. Percutaneous absorption of physiologically active peptides, ebiratide and elcatonin, in rats. Ogiso T; Paku T; Iwaki M; Tanino T; Nishioka S Biol Pharm Bull; 1994 Aug; 17(8):1094-100. PubMed ID: 7820115 [TBL] [Abstract][Full Text] [Related]
14. Improvement of intestinal absorption of water-soluble macromolecules by various polyamines: intestinal mucosal toxicity and absorption-enhancing mechanism of spermine. Gao Y; He L; Katsumi H; Sakane T; Fujita T; Yamamoto A Int J Pharm; 2008 Apr; 354(1-2):126-34. PubMed ID: 18206325 [TBL] [Abstract][Full Text] [Related]
15. Permeabilities of rebamipide via rat intestinal membranes and its colon specific delivery using chitosan capsule as a carrier. Huang BB; Li GF; Luo JH; Duan L; Nobuaki K; Akira Y World J Gastroenterol; 2008 Aug; 14(31):4928-37. PubMed ID: 18756602 [TBL] [Abstract][Full Text] [Related]
16. Improvement of intestinal absorption of forsythoside A in weeping forsythia extract by various absorption enhancers based on tight junctions. Zhou W; Qin KM; Shan JJ; Ju WZ; Liu SJ; Cai BC; Di LQ Phytomedicine; 2012 Dec; 20(1):47-58. PubMed ID: 23089157 [TBL] [Abstract][Full Text] [Related]
17. Improvement of absorption enhancing effects of n-dodecyl-beta-D-maltopyranoside by its colon-specific delivery using chitosan capsules. Fetih G; Lindberg S; Itoh K; Okada N; Fujita T; Habib F; Artersson P; Attia M; Yamamoto A Int J Pharm; 2005 Apr; 293(1-2):127-35. PubMed ID: 15778050 [TBL] [Abstract][Full Text] [Related]
18. Effect of permeability enhancers on paracellular permeability of acyclovir. Ates M; Kaynak MS; Sahin S J Pharm Pharmacol; 2016 Jun; 68(6):781-90. PubMed ID: 27061718 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of alkylmaltosides as intestinal permeation enhancers: comparison between rat intestinal mucosal sheets and Caco-2 monolayers. Petersen SB; Nolan G; Maher S; Rahbek UL; Guldbrandt M; Brayden DJ Eur J Pharm Sci; 2012 Nov; 47(4):701-12. PubMed ID: 22952065 [TBL] [Abstract][Full Text] [Related]
20. Regional Intestinal Drug Permeability and Effects of Permeation Enhancers in Rat. Dahlgren D; Cano-Cebrián MJ; Olander T; Hedeland M; Sjöblom M; Lennernäs H Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32182653 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]